BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+17.56%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.54B
AUM Growth
+$331M
(+5.3%)
Cap. Flow
-$370M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
179
New
25
Increased
33
Reduced
89
Closed
18
Top Buys
| 1 |
Immunocore
IMCR
|
$65.3M |
| 2 |
Biohaven
BHVN
|
$46M |
| 3 |
Moderna
MRNA
|
$41.1M |
| 4 |
GE HealthCare
GEHC
|
$40.4M |
| 5 |
Boston Scientific
BSX
|
$30.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$108M |
| 2 |
UnitedHealth
UNH
|
$63.2M |
| 3 |
Evolent Health
EVH
|
$42.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$34.5M |
| 5 |
IQVIA
IQV
|
$34M |
Sector Composition
| 1 | Healthcare | 99.06% |
| 2 | Industrials | 0.83% |
| 3 | Energy | 0.03% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
HCA Healthcare
HCA
$98.5B
| $41.2M | 0.63% |
152,178
-3,465
| -2% | -$938K |
|
52
Transmedics
TMDX
$3.55B
| $41M | 0.63% |
518,890
-17,847
| -3% | -$1.41M |
|
53
Scholar Rock
SRRK
$3.02B
| $40.8M | 0.62% |
2,168,925
+31,000
| +1% | +$583K |
|
54
Veeva Systems
VEEV
$44.7B
| $37.5M | 0.57% |
195,013
-29,087
| -13% | -$5.6M |
|
55
Procept Biorobotics
PRCT
$2.26B
| $37.1M | 0.57% |
885,346
-2,950
| -0.3% | -$124K |
|
56
Zimmer Biomet
ZBH
$20.9B
| $34.2M | 0.52% |
281,088
-3,800
| -1% | -$462K |
|
57
Molina Healthcare
MOH
$9.47B
| $33.1M | 0.51% |
91,476
-66,962
| -42% | -$24.2M |
|
58
Centene
CNC
$14.2B
| $32.8M | 0.5% |
441,853
-2,190
| -0.5% | -$163K |
|
59
Eli Lilly
LLY
$652B
| $32.8M | 0.5% |
56,212
-25,329
| -31% | -$14.8M |
|
60
Cooper Companies
COO
$13.5B
| $32.6M | 0.5% |
344,148
-2,120
| -0.6% | -$201K |
|
61
Globus Medical
GMED
$8.18B
| $32.4M | 0.5% |
607,772
-1,843
| -0.3% | -$98.2K |
|
62
Merck
MRK
$212B
| $31.6M | 0.48% |
290,206
-1,690
| -0.6% | -$184K |
|
63
BioMarin Pharmaceuticals
BMRN
$11.1B
| $31.4M | 0.48% |
325,776
-24,112
| -7% | -$2.32M |
|
64
AtriCure
ATRC
$1.76B
| $29.2M | 0.45% |
817,883
+70,323
| +9% | +$2.51M |
|
65
Castle Biosciences
CSTL
$683M
| $26.6M | 0.41% |
1,232,378
+4,347
| +0.4% | +$93.8K |
|
66
Cigna
CI
$81.5B
| $26.5M | 0.41% |
88,470
-37,032
| -30% | -$11.1M |
|
67
Cencora
COR
$56.7B
| $25.9M | 0.4% |
126,126
+109,039
| +638% | +$22.4M |
|
68
Privia Health
PRVA
$2.86B
| $24.2M | 0.37% |
1,051,696
-3,482
| -0.3% | -$80.2K |
|
69
Black Diamond Therapeutics
BDTX
$167M
| $24M | 0.37% |
8,535,839
+400,000
| +5% | +$1.12M |
|
|
SWAV
70
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $23.8M | 0.36% |
124,810
-129,469
| -51% | -$24.7M |
|
71
Sarepta Therapeutics
SRPT
$1.96B
| $22.9M | 0.35% |
237,286
-4,466
| -2% | -$431K |
|
72
Wave Life Sciences
WVE
$1.32B
| $22.7M | 0.35% |
4,494,458
| – | – |
|
73
Hologic
HOLX
$14.8B
| $20.7M | 0.32% |
289,864
-272
| -0.1% | -$19.4K |
|
74
HUTCHMED
HCM
$2.74B
| $20.4M | 0.31% |
1,131,111
-671,852
| -37% | -$12.1M |
|
75
Danaher
DHR
$143B
| $19.5M | 0.3% |
84,310
-69,699
| -45% | -$16.1M |
|